NPC1 Gene: Niemann-Pick Disease Type C1

A comprehensive biomedical overview of the NPC1 gene, its function, associated diseases, expression, mutations, and clinical significance.

Gene Information Card

Symbol NPC1
Full Name NPC intracellular cholesterol transporter 1
Gene Type protein-coding
Chromosomal Location 18q11.2
NCBI Gene ID 4864 ncbi.nlm.nih.gov/gene/4864
Ensembl ID ENSG00000141458
UniProt ID O15118
OMIM ID 607623
HGNC ID 7897
Aliases NPC, SLC65A1, Niemann-Pick disease, type C1

Description

The NPC1 gene encodes a large transmembrane protein that resides in the late endosome/lysosome and is essential for the intracellular trafficking of cholesterol and lipids. Mutations in NPC1 cause Niemann-Pick disease type C1 (NPC1), an autosomal recessive lysosomal storage disorder characterized by progressive neurodegeneration and hepatosplenomegaly. The protein functions in concert with NPC2 to mediate cholesterol export from lysosomes.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Niemann-Pick disease type C1 (NPC1) Loss-of-function mutations in NPC1 impair cholesterol and lipid trafficking, leading to lysosomal accumulation of unesterified cholesterol and glycosphingolipids. OMIM 257220; ClinVar; multiple publications
Niemann-Pick disease type C (broader phenotype) NPC1 mutations account for ~95% of NPC cases; the remainder are due to NPC2 mutations. OMIM; GeneReviews
Hepatocellular carcinoma (potential association) Altered NPC1 expression may affect cholesterol homeostasis and tumor progression, but evidence is preliminary. COSMIC; limited studies

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 10.2 Medium
Brain 8.5 Medium
Lung 6.3 Low
Kidney 5.1 Low
Spleen 7.8 Medium
Cell Line Expression
Cell Line nTPM Notes
HepG2 12.4 Liver cancer cell line; high expression
SH-SY5Y 9.8 Neuroblastoma; moderate expression
A549 7.2 Lung carcinoma; moderate
HeLa 6.5 Cervical carcinoma; moderate
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.3182T>C (p.I1061T) Missense ~15-20% of NPC1 alleles in Western populations Common pathogenic variant; causes protein misfolding and reduced function
c.3019C>T (p.R1007C) Missense Rare Pathogenic; disrupts sterol-sensing domain
c.3599A>G (p.N1200S) Missense Rare Pathogenic; affects protein stability
c.1628delC (frameshift) Frameshift Rare Loss-of-function; leads to truncated protein
Mutation functional classification

Loss of Function (LOF)

Most NPC1 mutations are loss-of-function, leading to impaired cholesterol export from lysosomes. This results in lysosomal lipid accumulation and cellular dysfunction.

Gain of Function (GOF)

No gain-of-function mutations have been reported for NPC1; all known pathogenic variants are loss-of-function.

Dominant Negative (DN)

NPC1 is autosomal recessive; no dominant-negative effects are documented. Heterozygous carriers are typically asymptomatic.

Gene Ontology (GO)

• cholesterol binding • lipid transporter activity
• sterol transporter activity • late endosome membrane
• lysosomal membrane • cholesterol homeostasis
• intracellular cholesterol transport • response to sterol depletion

Pathways

• Cholesterol metabolism
• Sphingolipid metabolism
• Lysosomal transport
• NPC1/NPC2-mediated cholesterol transport

Protein Summary

The NPC1 protein is a 1278-amino-acid glycoprotein with 13 transmembrane domains, a sterol-sensing domain, and a luminal N-terminal domain that binds cholesterol. It localizes to late endosomes/lysosomes and interacts with NPC2 to facilitate cholesterol egress. Mutations cause Niemann-Pick type C1, a neurodegenerative lysosomal storage disease.

Related Products

Product name Cat.No. Species Gene ID
NPC1L1 Knockout Huh-7 Cell Line EDC08353 Human 29881 Details Get a Quote
NPC1L1 Knockout HCT 116 Cell Line EDJ-KQ73053 Human 29881 Details Get a Quote
NPC1L1 Knockout A-549 Cell Line EDC08212 Human 29881 Details Get a Quote
NPC1L1 Knockout HeLa Cell Line EDJ-KQ56115 Human 29881 Details Get a Quote
NPC1 Knockout A-549 Cell Line EDJ-KQ43431 Human 4864 Details Get a Quote
NPC1 Knockout HeLa Cell Line EDJ-KQ44690 Human 4864 Details Get a Quote
NPC1 Knockout HCT 116 Cell Line EDJ-KQ44689 Human 4864 Details Get a Quote
NPC1 Knockout HEK293 Cell Line EDJ-KQ14457 Human 4864 Details Get a Quote
NPC1L1 Knockout HEK293 Cell Line EDJ-KQ3813 Human 29881 Details Get a Quote
NPC1 Knockout HEK293T Cell Line EDJ-KQ240 Human 4864 Details Get a Quote

Research Areas

Cellular Metabolism and Metabolic Reprogramming: A Complete Map from Pathways to Validated Cell Models

Glucose Metabolism and Energy Homeostasis: Flux Control from Glycolysis to OXPHOS

Validating the Glycolysis-OXPHOS Switch by Gene Knockout

Functional Validation of Glycolytic Enzymes (HK2 / PKM2 / LDHA)

TCA Cycle and Mitochondrial Respiration Readouts

Pentose Phosphate Pathway and NADPH Homeostasis

Regulation of Gluconeogenesis and Glycogen Metabolism

Lactate Metabolism and MCT Transporters

Setting Up the Seahorse Glycolysis Stress Test

Troubleshooting Unstable ECAR/OCR Baselines

2-DG Concentration and Duration for Glycolysis Inhibition

Choosing a Lactate Assay

Why Glycolysis Persists After HK2 Knockout

Measuring Glucose Uptake with 2-NBDG

Glycogen Content Assays

How to Measure Pentose Phosphate Pathway Flux

Lipid Metabolism and Lipotoxicity: From Fatty Acid Oxidation to Lipid Droplet Homeostasis

Fatty Acid Oxidation (CPT1A/ACADM) and Lipotoxicity Validation

De Novo Lipogenesis (ACC/FASN/SCD1): Regulation and Validation

Cholesterol Metabolism and the SREBP/SCAP Pathway

Sphingolipid and Ceramide Metabolism

Lipid Droplet Biology and Perilipins

Phospholipid Metabolism and Membrane Homeostasis

BODIPY vs Oil Red O for Lipid Droplets

Palmitate-Induced Lipotoxicity: Concentration and BSA Conjugation

Using Etomoxir to Inhibit Fatty Acid Oxidation

Triglyceride Quantification Assays

Reading the Phenotype After SCD1 Knockout

Ceramide Detection Methods

Lipid Droplet Isolation and Proteomics

Designing a Cholesterol Efflux Assay

Amino Acid and One-Carbon Metabolism: Nitrogen Balance, Glutaminolysis and Methyl Donors

Glutaminolysis (GLS) and Metabolic Dependency

Serine-Glycine Metabolism and One-Carbon Units

Methionine Cycle and the SAM/SAH Ratio

Nucleotide Metabolism and Antimetabolites

Urea Cycle and Nitrogen Metabolism

Branched-Chain Amino Acid Catabolism

Using CB-839 to Inhibit GLS

Preparing Serine-Free Medium

Measuring the SAM/SAH Ratio

LC-MS Profiling of Nucleotide Pools

Urea Quantification Assays

BCAA Detection and Analysis

Setting Glutamine Concentration in Culture

Designing One-Carbon Flux Tracing

Mitochondrial Metabolism and Reprogramming: OXPHOS, Metabolite Signaling and Cancer

Validating the Warburg Effect and Glycolytic Phenotype

Respiratory Chain Complexes and OXPHOS-Deficient Models

Oncometabolites (Succinate/Fumarate/2-HG) and Epigenetic Crosstalk

Mitochondrial Dynamics and Metabolic Adaptation

Hypoxic Metabolism and HIF Reprogramming

Metabolic Flux and Stable Isotope Tracing

Using Rotenone and Antimycin A

Detecting 2-Hydroxyglutarate

Seahorse Mito Stress Test Parameters

Analyzing 13C Tracing Data

Membrane Potential and OXPHOS Readouts

Building an OXPHOS-Deficient Cell Line

Setting Hypoxic Culture Conditions

Building a Succinate Accumulation Model

Metabolism and Disease: From Obesity and Diabetes to Cancer and Immunometabolism

Insulin Resistance and Glucolipid Metabolic Models

NAFLD/MASH Cell Models and Lipotoxicity

Tumor Metabolic Dependency and Target Validation

Immunometabolism and T Cell Metabolism

Metabolic Syndrome and Adipocyte Models

Synthetic Lethality of Metabolic Enzymes

How to Induce Insulin Resistance In Vitro

Building a Hepatocyte Lipid Droplet Model

Running Seahorse Assays on T Cells

Adipocyte Differentiation Protocol

Designing a Synthetic Lethality Screen

Measuring Metabolism in Tumor Spheroids

High-Glucose High-Fat Culture Conditions

Choosing a Metabolic Disease Model

Custom Metabolic Reporter Cell Lines

Custom Knockout Cell Lines for Metabolic Pathways

Metabolic Phenotyping and Seahorse Analysis Service

Stable Isotope Tracing and Metabolomics Capabilities

Metabolic Model Service Provider Comparison

Single-Cell Metabolomics: A Detection Field Waiting for a Measurement Standard

Spatial Metabolomics: The Location Is the Measurement, and the Preparation Moves It

AI Metabolic Network Modeling: The Bottleneck Is the Constraint Set, Not the Architecture

Metabolite-Epigenetics Crosstalk: From Substrate to Signal, Without the Causal Standard

Metabolism in Organoids and 3D Culture: The Gradient Is the Finding, and It Is Usually Unreported

Contact Us
*
*
*
How did you hear about us: